Effects of Food and Drug Administration‐approved medications for Alzheimer's disease on clinical progression-Reference-Cited by-同舟云学术

Effects of Food and Drug Administration‐approved medications for Alzheimer's disease on clinical progression

Published:2012-02-03 Issue:3 Volume:8 Page:180-187
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Mielke Michelle M.¹,Leoutsakos Jeannie‐Marie¹,Corcoran Chris D.²³,Green Robert C.⁴,Norton Maria C.²⁵⁶,Welsh‐Bohmer Kathleen A.⁷,Tschanz JoAnn T.²⁵,Lyketsos Constantine G.¹

Affiliation:

1. Department of PsychiatryDivision of Geriatric Psychiatry and NeuropsychiatryJohns Hopkins University School of MedicineBaltimoreMDUSA

2. Division of Epidemiologic StudiesUtah State UniversityLoganUTUSA

3. Department of Mathematics and StatisticsUtah State UniversityLoganUTUSA

4. Departments of Neurology, Medicine (Genetics), and EpidemiologyBoston University Schools of Medicine and Public HealthBostonMAUSA

5. Department of PsychologyUtah State UniversityLoganUTUSA

6. Department of Family, Consumer and Human DevelopmentUtah State UniversityLoganUTUSA

7. Department of Psychiatry and Behavioral Sciences and the Joseph and Kathleen Bryan Alzheimer's Disease Research CenterDuke UniversityDurhamNCUSA

Funder

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2011.02.011

Reference33 articles.

1. Patterns of cholinesterase-inhibitor use in the nursing home setting: A retrospective analysis

2. Pharmacologic Management of Neuropsychiatric Symptoms of Alzheimer Disease

3. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease;Mucha L;J Manag Care Pharm,2008

4. ZhuCW LivoteEE Kahle‐WrobleskiK ScarmeasN AlbertM BrandtJ BlackerD SanoM SternY.Longitudinal Medication Usage in Alzheimer Disease Patients.Alzheimer Dis Assoc Disord(in press).

5. Identifying Dementia in High-Risk Community Samples: The Memory and Medical Care Study

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effectiveness of Centella asiatica Extract and Aerobic Exercise on Plasma Levels of Amyloid Beta-42 and Phosphorylated Tau in Older Women with Dementia;International Journal of Disabilities Sports & Health Sciences;2024-09-03

2. Effectiveness of the online-based comprehensive cognitive training application, Smart Brain, for community-dwelling older adults with dementia: a randomized controlled trial;European Journal of Physical and Rehabilitation Medicine;2024-07

3. Rivastigmine nasal spray for the treatment of Alzheimer’s Disease: Olfactory deposition and brain delivery;International Journal of Pharmaceutics;2024-03

4. Alzheimer’s Disease and Related Dementias: A Review of Evidence for Clinical Exercise Physiologists;Journal of Clinical Exercise Physiology;2024-03-01

5. Organophospate-Induced Pathology: Mechanisms of Development, Principles of Therapy and Features of Experimental Studies;Российский физиологический журнал им И М Сеченова;2023-10-01